Illumina, Inc. vs Target Corporation — how do they compare? Illumina, Inc. trades at $278.17 (market cap $39.95B), while Target Corporation trades at $153.77 (market cap $70.31B). The key difference: Target Corporation is the larger of the two by market cap, and Target Corporation pays a 3% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Target Corporation for 137 Days on average.
| ILMN | TGT | |
|---|---|---|
Market Cap | $39.95B | $70.31B |
Volume | 3,169,503 | 4,164,999 |
Sector | Health | Consumer Staples |
52-Week High | $293.69 | $169.90 |
52-Week Low | $91.00 | $83.68 |
Typical Hold Time | 83 Days | 137 Days |
Enterprise Value | $41.31B | $83.58B |
Dividend Yield | — | 3% |
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $264.40, down 1.25% on the day but remains near its 52-week high of $278.99, reflecting strong momentum with a 94.9% YTD gain. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Fundamentals show a significant turnaround, with net income reaching $850 million in 2025 after prior losses, supported by robust gross margins of 66.38%. Technical indicators are bullish overall, with key support at $257 and resistance at $268.
The outlook for ILMN is positive, driven by earnings momentum, inclusion in the S&P 500, and strategic AI initiatives in genomics. However, risks include high valuation multiples, such as a P/E of 49.36, and potential margin pressure from cost volatility. Analyst consensus is bullish with a 54% buy rating, though the consensus price target of $241 suggests limited near-term upside from current levels.
Target Corporation (TGT) trades at $154.76, up 2.52% today, with strong earnings momentum after beating expectations for three consecutive quarters. The stock shows bearish technical signals but maintains solid fundamentals with a 26.41% ROE and 4.08% net margin. Recent price cuts on 2,000 items aim to capture holiday market share, while analyst consensus remains balanced with a $167.18 price target suggesting 8% upside potential.
Target presents a mixed investment case with strong profitability metrics and consistent dividend payments offset by bearish technical indicators and competitive retail pressures. The company's turnaround strategy shows early signs of traction, but execution risks and margin pressures from aggressive pricing remain key concerns for investors seeking exposure to the retail sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →